I would say, unlike peers we disclose and quantify the humanoid line and it is real and small. We shipped about $600,000 of foil strain gages to humanoid makers in Q1 2026, used in pre‑production prototypes, and we expect to more than double that in Q2. At this point in time there are two established pre‑production customers, early engineering discussions with a third and a fourth startup building platforms for defense, home and industrial use. Since we have no visibility we took 2025 as a baseline, adoption is still fairly low, we remain in pre‑production, and anything can happen.